Immunology

Latest News

dna and therapy changes | Image credit: Ilya - stock.adobe.com
Danish Registry Analysis Finds Consistent Safety After Switching to Infliximab Biosimilar GP1111

February 3rd 2026

New Danish registry data confirm the safety of switching to infliximab biosimilars, showing low rates of serious adverse events in patients with inflammatory arthritis.

DNA syringe | Image credit: natali_mis - stock.adobe.com
Denosumab, Golimumab Biosimilars Clear Major Regulatory Milestones in Europe, as US Hurdles Remain

December 16th 2025

AI gen syringe | Image credit: DachAI - stock.adobe.com
Patient Experiences With CT-P17 Suggest Strong Satisfaction and Ease of Injection

November 25th 2025

adalimumab auto-injector pen | Image credit: Orawan - stock.adobe.com
Real-World Data Highlight Adalimumab Biosimilar Options for Hidradenitis Suppurativa

November 21st 2025

Latest CME Events & Activities

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

View More

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

1.5 Credits / Immunology, Allergy

View More

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

1.5 Credits / Immunology, Pulmonology

View More

Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Car...

1.5 Credits / Immunology

View More

Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition

1.5 Credits / Gastroenterology, Immunology

View More

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care...

1.5 Credits / Gastroenterology, Immunology

View More

The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updat...

1.0 Credit / Immunology, Nephrology

View More

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

1.0 Credit / Immunology, Nephrology

View More

Payment for Pharmacist Services: 2025 Update

1.0 Credit / General Pharmacy, Health Equity, Diversity & Inclusion, Law

View More

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

1.0 Credit / Immunology, Rare Diseases

View More

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape

1.0 Credits / Dermatology, Immunology

View More

Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes

2.0 Credits / Immunology, Rare Diseases, Hematology

View More

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

1.0 Credit / Immunology, Neurology, Rare Diseases

View More

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

1.0 Credits / Dermatology, Immunology

View More

The Expanding Therapeutic Landscape in IgA Nephropathy: Translating New Clinical Evidence and Updated Guidelin...

1.0 Credit / Immunology, Nephrology

View More

<1
...
78
© 2026 MJH Life Sciences

All rights reserved.